Histone deacetylase inhibitors rescue the impaired memory in terrestrial snails

被引:0
|
作者
Alena B. Zuzina
Alia Kh. Vinarskaya
Pavel M. Balaban
机构
[1] Russian Academy of Sciences,Institute of Higher Nervous Activity and Neurophysiology
来源
关键词
Sodium butyrate; Trichostatin A; Memory reinstatement; Gastropods; Epigenetics;
D O I
暂无
中图分类号
学科分类号
摘要
It is becoming increasingly clear that the long-term plasticity can be regulated via histone modifications. Many studies demonstrated the role of histone acetylation in acquisition, maintenance, and extinction of long-term memory. Nonetheless, the role of histone acetylation in memory reinstatement following its disruption by antimnemonic treatments was not studied in details. In terrestrial snails, we examined effects of the histone deacetylases inhibitors (HDACi) sodium butyrate (NaB) and trichostatin A (TSA) on reinstatement of the context fear memory impaired by antimnemonic agents such as protein synthesis blocker anisomycin (ANI) + reminding or a specific inhibitor of protein-kinase Mζ, zeta inhibitory peptide (ZIP). It was observed that both NaB and TSA applications restored the ANI-impaired context memory regardless of memory reactivation, while a combination of NaB or TSA plus memory reactivation (or additional training) was necessary for the effective reinstatement of the ZIP-impaired memory. Additionally, NaB injections significantly facilitated development of long-term memory in animals with weak memory, while no effect was observed in animals with strong memory. The data obtained confirmed the assumption that histone acetylation is a critical regulatory component of memory development and reinstatement.
引用
收藏
页码:639 / 649
页数:10
相关论文
共 50 条
  • [21] Editorial: Histone deacetylase inhibitors
    Hadjipavlou-Litina, Dimitra
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (06) : 504 - 504
  • [22] Histone deacetylase inhibitors in lymphoma
    Copeland, Amanda
    Buglio, Daniela
    Younes, Anas
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (05) : 431 - 436
  • [23] Pharmacogenomics and histone deacetylase inhibitors
    Goey, Andrew K. L.
    Sissung, Tristan M.
    Peer, Cody J.
    Figg, William D.
    PHARMACOGENOMICS, 2016, 17 (16) : 1807 - 1815
  • [24] Histone deacetylase inhibitors.
    Richon, VM
    Breslow, R
    Rifkind, RA
    Marks, PA
    CLINICAL CANCER RESEARCH, 2000, 6 : 4478S - 4478S
  • [25] Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
    Phimmachanh, Monica
    Han, Jeremy Z. R.
    O'Donnell, Yolande E., I
    Latham, Sharissa L.
    Croucher, David R.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [26] Histone deacetylase inhibitors and demethylating agents: Clinical development of histone deacetylase inhibitors for cancer therapy
    Piekarz, Richard L.
    Sackett, Dan L.
    Bates, Susan E.
    CANCER JOURNAL, 2007, 13 (01): : 30 - 39
  • [27] Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides
    Amin, Sk. Abdul
    Adhikari, Nilanjan
    Kotagiri, Sonali
    Jha, Tarun
    Ghosh, Balaram
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 166 : 369 - 380
  • [28] Immunomodulatory Effects of Histone Deacetylase Inhibitors
    Licciardi, P. V.
    Ververis, K.
    Tang, M. L.
    El-Osta, A.
    Karagiannis, T. C.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (04) : 640 - 647
  • [29] Effects of histone deacetylase inhibitors on alloresponses
    Hancock, Wayne W.
    LANCET ONCOLOGY, 2014, 15 (01): : 10 - 11
  • [30] Dietary agents as histone deacetylase inhibitors
    Myzak, Melinda C.
    Ho, Emily
    Dashwood, Roderick H.
    MOLECULAR CARCINOGENESIS, 2006, 45 (06) : 443 - 446